Proactive Insight
Daraxonrasib, which nearly doubled patients’ survival time, fights the disease in a new way. It bear-hugs a cancer protein that drives cell growth.
Also Read
- ChatGPT on Mac can now read and respond to Apple iMessages
- Europe Endures Historic Summer Heat Waves, Leaving Devastating Impact on Communities
- Cisco Rates Secure Workload Vulnerabilities with Scores Ranging from 7.5 to Perfect 10
- Innovative Scientific Solutions: How Phages, Smart Packaging, and Edible Coatings Are Combating Global Food Waste